{"id":40986,"date":"2025-09-09T14:08:43","date_gmt":"2025-09-09T06:08:43","guid":{"rendered":"https:\/\/flcube.com\/?p=40986"},"modified":"2025-09-09T14:08:44","modified_gmt":"2025-09-09T06:08:44","slug":"nmpa-releases-online-prescription-compliance-guidelines-to-tighten-drug-retail-oversight","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=40986","title":{"rendered":"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight"},"content":{"rendered":"\n<p>The National Medical Products Administration (NMPA) issued a draft of its <strong>Compliance Guidelines for Online Retail of Prescription Drugs<\/strong>, inviting public comment until September 15. The guidelines aim to strengthen drug\u2011safety oversight of e\u2011pharmacies and ensure that all prescription sales are traceable and sourced from legal channels.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-pillars-of-the-draft\">Key Pillars of the Draft<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th><strong>Area<\/strong><\/th><th><strong>Mandate<\/strong><\/th><\/tr><\/thead><tbody><tr><td><strong>Safety &amp; Quality<\/strong><\/td><td>Companies must shoulder full responsibility for drug safety and continuously enhance their quality\u2011management systems across procurement, storage, sales, and transport.<\/td><\/tr><tr><td><strong>Licensing &amp; Transparency<\/strong><\/td><td>Online retailers must be licensed by regulatory authorities and disclose details (name, website, domain, IP address, and drug\u2011business licence) to the NMPA. Any changes must be reported within 10 working days.<\/td><\/tr><tr><td><strong>Operational Standards<\/strong><\/td><td>Establish an online pharmaceutical service system that aligns with Good Pharmacy Practice (GPP) guidelines and its appendices.<\/td><\/tr><tr><td><strong>Prescription Review Limits<\/strong><\/td><td>Pharmacists are capped at 300 prescriptions per day; exceeding this triggers intensified monitoring of review quality and behavior.<\/td><\/tr><tr><td><strong>Prohibited Activities<\/strong><\/td><td>Selling unapproved drugs or offering storage\/transport services for them is illegal. Platforms facilitating such activities face severe liability.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-implications-for-online-pharmacies\">Implications for Online Pharmacies<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Compliance Burden<\/strong> \u2013 Retailers must overhaul IT systems to capture and report the required data in real time.<\/li>\n\n\n\n<li><strong>Risk\u2011Based Monitoring<\/strong> \u2013 Third\u2011party platforms are encouraged to implement dynamic risk\u2011analysis tools to flag non\u2011standard prescriptions, inappropriate medication use, irregular orders, and multiple purchases from a single account.<\/li>\n\n\n\n<li><strong>Quarterly Audits<\/strong> \u2013 Platforms should conduct retrospective reviews of prescription usage and sales to identify and mitigate risks promptly.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-industry-reactions\">Industry Reactions<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pharmaceutical Companies<\/strong> applaud the focus on safety but caution that the reporting requirements may strain smaller e\u2011pharmacies.<\/li>\n\n\n\n<li><strong>Retail Platforms<\/strong> are expected to invest in compliance\u2011automation solutions to meet the new thresholds and avoid potential penalties.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-next-steps\">Next Steps<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Public Commentary<\/strong> \u2013 Stakeholders can submit comments until <strong>September\u202f15<\/strong> via the NMPA portal.<\/li>\n\n\n\n<li><strong>Finalization<\/strong> \u2013 The NMPA will review feedback and publish the final guidelines, likely in the first half of 2026.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Medical Products Administration (NMPA) issued a draft of its Compliance Guidelines for Online&#8230;<\/p>\n","protected":false},"author":1,"featured_media":40987,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[14],"class_list":["post-40986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Medical Products Administration (NMPA) issued a draft of its Compliance Guidelines for Online Retail of Prescription Drugs, inviting public comment until September\u202f15. The guidelines aim to strengthen drug\u2011safety oversight of e\u2011pharmacies and ensure that all prescription sales are traceable and sourced from legal channels.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=40986\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight\" \/>\n<meta property=\"og:description\" content=\"The National Medical Products Administration (NMPA) issued a draft of its Compliance Guidelines for Online Retail of Prescription Drugs, inviting public comment until September\u202f15. The guidelines aim to strengthen drug\u2011safety oversight of e\u2011pharmacies and ensure that all prescription sales are traceable and sourced from legal channels.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=40986\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-09T06:08:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-09T06:08:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0908.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight\",\"datePublished\":\"2025-09-09T06:08:43+00:00\",\"dateModified\":\"2025-09-09T06:08:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986\"},\"wordCount\":328,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0908.webp\",\"keywords\":[\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40986#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=40986\",\"name\":\"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0908.webp\",\"datePublished\":\"2025-09-09T06:08:43+00:00\",\"dateModified\":\"2025-09-09T06:08:44+00:00\",\"description\":\"The National Medical Products Administration (NMPA) issued a draft of its Compliance Guidelines for Online Retail of Prescription Drugs, inviting public comment until September\u202f15. The guidelines aim to strengthen drug\u2011safety oversight of e\u2011pharmacies and ensure that all prescription sales are traceable and sourced from legal channels.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40986\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0908.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/0908.webp\",\"width\":1080,\"height\":608,\"caption\":\"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40986#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight - Insight, China&#039;s Pharmaceutical Industry","description":"The National Medical Products Administration (NMPA) issued a draft of its Compliance Guidelines for Online Retail of Prescription Drugs, inviting public comment until September\u202f15. The guidelines aim to strengthen drug\u2011safety oversight of e\u2011pharmacies and ensure that all prescription sales are traceable and sourced from legal channels.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=40986","og_locale":"en_US","og_type":"article","og_title":"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight","og_description":"The National Medical Products Administration (NMPA) issued a draft of its Compliance Guidelines for Online Retail of Prescription Drugs, inviting public comment until September\u202f15. The guidelines aim to strengthen drug\u2011safety oversight of e\u2011pharmacies and ensure that all prescription sales are traceable and sourced from legal channels.","og_url":"https:\/\/flcube.com\/?p=40986","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-09T06:08:43+00:00","article_modified_time":"2025-09-09T06:08:44+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0908.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=40986#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=40986"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight","datePublished":"2025-09-09T06:08:43+00:00","dateModified":"2025-09-09T06:08:44+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=40986"},"wordCount":328,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=40986#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0908.webp","keywords":["NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=40986#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=40986","url":"https:\/\/flcube.com\/?p=40986","name":"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=40986#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=40986#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0908.webp","datePublished":"2025-09-09T06:08:43+00:00","dateModified":"2025-09-09T06:08:44+00:00","description":"The National Medical Products Administration (NMPA) issued a draft of its Compliance Guidelines for Online Retail of Prescription Drugs, inviting public comment until September\u202f15. The guidelines aim to strengthen drug\u2011safety oversight of e\u2011pharmacies and ensure that all prescription sales are traceable and sourced from legal channels.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=40986#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=40986"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=40986#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0908.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0908.webp","width":1080,"height":608,"caption":"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=40986#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NMPA Releases Online Prescription Compliance Guidelines to Tighten Drug Retail Oversight"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/0908.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40986"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40986\/revisions"}],"predecessor-version":[{"id":40988,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40986\/revisions\/40988"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/40987"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}